Emerson Process Management reported a sales decline of 13% for the quarter, which included a 9% decline in underlying sales, a negative 7% currency impact, and a positive 3% impact from the Roxar acquisition. Underlying sales from international markets were down 4% while sales in the United States declined 18%.
